CHRS R&D Expenses
Coherus Oncology Inc · R&D Expenses
CHRS R&D Expenses
Latest reported$21.44Mperiod ending
CHRS Quarterly R&D Expenses ($8.66M → $21.44M)
Quarterly R&D Expenses
High-resolution chart · PNG
CHRS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 21,442,000 | |
| 20,662,000 | |
| 30,078,000 | |
| 26,286,000 | |
| 25,290,000 | |
| 23,310,000 | |
| 21,235,000 | |
| 21,676,000 | |
| 20,768,000 | |
| 28,424,000 | |
| 26,368,000 | |
| 25,647,000 | |
| 23,267,000 | |
| 34,154,000 | |
| 29,022,000 | |
| 45,808,000 | |
| 41,611,000 | |
| 82,917,000 | |
| 50,762,000 | |
| 54,085,000 | |
| 54,766,000 | |
| 203,492,000 | |
| 44,628,000 | |
| 38,851,000 | |
| 26,173,000 | |
| 33,107,000 | |
| 34,948,000 | |
| 21,568,000 | |
| 18,883,000 | |
| 18,789,000 | |
| 26,662,000 | |
| 31,603,000 | |
| 26,519,000 | |
| 25,455,000 | |
| 31,488,000 | |
| 42,626,000 | |
| 34,500,000 | |
| 53,775,000 | |
| 59,010,000 | |
| 64,573,000 | |
| 65,544,000 | |
| 65,313,000 | |
| 51,433,000 | |
| 68,218,000 | |
| 56,944,000 | |
| 36,467,000 | |
| 26,867,000 | |
| 18,496,000 | |
| 18,925,000 | |
| 13,936,000 | |
| 9,222,000 | |
| 4,934,000 | |
| 8,967,000 | |
| 8,656,000 |